天际股份被立案！上月刚收监管函

Core Viewpoint - Tianji Co., Ltd. is currently facing regulatory scrutiny due to multiple violations identified by the Shenzhen Stock Exchange and the China Securities Regulatory Commission, which may impact its operations and governance [2][4]. Regulatory Issues - The Shenzhen Stock Exchange issued a regulatory letter on January 15, highlighting several violations by Tianji Co., Ltd. and its executives, including improper goodwill impairment testing for subsidiaries [2]. - Specific violations include non-compliance in goodwill impairment testing for Jiangsu Xintai Material Technology Co., Ltd. and Changshu Yuxiang Trading Co., Ltd. for the years 2023 and 2024 [2]. - The company and its subsidiary, Changshu Xinte Chemical Co., Ltd., failed to appropriately accrue salaries for sales and management personnel from September 2023 to December 2024 [3]. - Tianji Co., Ltd. provided financial assistance to non-related parties without following the required approval procedures and disclosure obligations from September 2023 to August 2025 [4]. Management Accountability - The actions of Tianji Co., Ltd. and its executives, including Chairman and General Manager Wu Xidun, CFO Yang Zhixuan, and Secretary of the Board Zheng Wenlong, have been deemed as failing to fulfill their duties and responsibilities, leading to administrative penalties [4]. Business Performance - On January 15, Tianji Co., Ltd. released its earnings forecast for 2025, projecting a net profit attributable to shareholders of between 70 million and 105 million yuan, a significant turnaround from a loss of 1.361 billion yuan in the previous year [5]. - The company attributes this expected recovery to the rapid growth in demand within the new energy vehicle and energy storage markets, leading to an increase in sales prices for its main product, lithium hexafluorophosphate, in the fourth quarter of 2025 [5].